Siobhan Ashmore

As Partner of ELIQUENT Life Sciences, Siobhan Ashmore advises and supports life science companies navigate complex problems in adherence to global regulations from start-up to commercialization while accelerating innovation and ensuring patient safety.

Siobhan Ashmore brings over 30 years of global experience across the life sciences industry, supporting organizations ranging from startups to multinational pharmaceutical, biotechnology, medical device, dietary supplement, and compounding pharmacies.

Having worked with leading life science companies including Pfizer, Amgen, Johnson & Johnson, Abbott, Ro Healthcare, and many others. Siobhan has extensive expertise in regulatory strategy, new product submissions, CMC, quality systems, manufacturing processes, formulation development, and global regulatory compliance. Her experience spans North America, Europe, and the Asia-Pacific region, enabling her to effectively navigate diverse regulatory environments and complex compliance challenges.

Throughout her career, Siobhan has successfully guided organizations through regulatory inspections, inspection readiness programs, FDA Form 483 observation responses, Warning Letter remediation, and Consent Decree compliance initiatives. She is widely recognized for her ability to strengthen quality systems, mitigate regulatory risk, and establish sustainable compliance frameworks across global operations.

Siobhan spent 10 years as a Global Auditor with Pfizer, where she developed deep expertise in quality assurance, auditing, and regulatory oversight within complex international organizations. She has also served on behalf of State Boards of Pharmacy as both a 503A and 503B Pharmacy Inspector, providing valuable governance, compliance, and regulatory enforcement expertise within the compounding pharmacy sector.

In addition to her regulatory and quality leadership experience, Siobhan serves as a trusted board-level advisor on risk management, compliance, corporate governance, and scalable growth strategies for emerging biotechnology and life sciences companies. She works closely with startup organizations to support enterprise value creation, operational scaling, investor readiness, digital transformation initiatives, AI governance frameworks, and global regulatory strategies that strengthen organizational resilience and build investor confidence.

Her broad industry experience, combined with a comprehensive understanding of regulatory requirements, quality systems, operational excellence, and strategic growth, enables her to help organizations achieve compliance objectives, enhance performance, accelerate innovation, and successfully navigate evolving global regulatory expectations.